Home › Seizures › New Jersey
Seizures clinical trials in New Jersey
8 studies for Seizures are looking for participants at sites in New Jersey.
Cities in New Jersey
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Northeast Regional Epilepsy Group, Hackensack
- Institute of Neurology and Neurosurgery at St. Barnabas, Livingston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07563881Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 4 to 55 · All sexes · Updated Nov 6, 2026 · NCT05219617A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT05716100A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Hackensack Meridian Neuroscience Institute at JFK University Medical Center, Edison
- Saint Peter's University Hospital, New Brunswick
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 29, 2026 · NCT07233239A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Neurology Center for Epilepsy and Seizures, Marlboro
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Oct 29, 2026 · NCT04462770An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Tekton Research, Marlboro
RecruitingPhase 3
Ages 2 to 55 · All sexes · Updated Oct 9, 2026 · NCT05066217RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Northeast Regional Epilepsy Group - Hackensack, Hackensack
- Hackensack Meridian Health Jersey Shore University Medical Center, Neptune City
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 1, 2026 · NCT06798896An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Hackensack
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 3, 2025 · NCT06908356From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.